Cardiovascular Systems, Inc. to Participate at Four Upcoming Investor Conferences

心血管系统公司将参加即将举行的四次投资者会议

2021-02-11 21:02:29 BioSpace

本文共722个字,阅读需2分钟

ST. PAUL, Minn.----Cardiovascular Systems, Inc.  , a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at three upcoming conferences. Webcasts of each of the presentations will be made available on CSI's website. 10th Annual SVB Leerink Global Heathcare Conference Thursday, February 25, 2021 9:20 a.m. ET 42nd Annual Raymond James Institutional Investors Conference Tuesday, March 2, 2021 3:00 p.m. ET Barclays Global Healthcare Conference Tuesday, March 9, 2021 2:25 p.m. ET 31st Annual Oppenheimer Healthcare Conference Tuesday, March 16, 2021 2:30 p.m. ET About Cardiovascular Systems, Inc. Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360. View source version on businesswire.com: https://www.businesswire.com/news/home/20210211005043/en/ Cardiovascular Systems, Inc. Jack Nielsen (651) 202-4919 j.nielsen@csi360.com Source: Cardiovascular Systems, Inc. View this news release online at: http://www.businesswire.com/news/home/20210211005043/en
明尼苏达州圣保罗市----心血管系统公司,一家为周围血管和冠状动脉疾病患者开发和商业化创新介入治疗系统的医疗器械公司,今天宣布管理层计划在即将举行的三次会议上介绍和主办投资者会议。每个专题介绍的网播将在基督教团结倡议的网站上提供。 第十届SVB Leerink全球卫生保健年会 2021年2月25日星期四 美国东部时间上午9:20 第42届Raymond James机构投资者年会 2021年3月2日,星期二 东部时间下午3:00 巴克莱全球医疗保健会议 2021年3月9日,星期二 美国东部时间下午2:25 第31届奥本海默医疗保健年会 2021年3月16日,星期二 东部时间下午2时30分 心血管系统公司简介。 心血管系统公司总部设在明尼苏达州圣保罗,是一家专注于开发和商业化治疗血管和冠状动脉疾病的创新解决方案的医疗器械公司。该公司的眼眶动脉粥样硬化切除系统可治疗腿部和心脏动脉血管中的钙化和纤维化斑块,并解决了与现有手术、导管和药物治疗替代方案相关的许多限制。欲了解更多信息,请访问www.csi360.com,并在Twitter@csi360上连接。 在businesswire.com上查看源版本:https://www.businesswire.com/news/home/20210211005043/en/ 心血管系统公司。 杰克·尼尔森 (651)202-4919 @csi360.com j.nielsen@csi360.com 资料来源:心血管系统公司。 请在以下网址联机查看此新闻稿: http://www.businesswire.com/news/home/20210211005043/en

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文